Regeneron Pharmaceuticals (REGN)
602.33 x 2 N/A x N/A
Post-market by (Cboe BZX)
625.60 +8.60 (+1.39%) 04/02/25 [NASDAQ]
602.33 x 2 N/A x N/A
Post-market 602.33 -23.27 (-3.72%) 19:05 ET
for Wed, Apr 2nd, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,488,200 | 2,730,000 | 3,105,900 | 2,885,600 | 2,193,700 |
| Marketable Securities | 6,524,300 | 8,114,800 | 4,636,400 | 2,809,100 | 1,393,300 |
| Receivables | 6,211,900 | 5,667,300 | 5,328,700 | 6,036,500 | 4,114,700 |
| Inventories | 3,087,300 | 2,580,500 | 2,401,900 | 1,951,300 | 1,916,600 |
| TOTAL | $18,660,900 | $19,479,200 | $15,884,100 | $14,014,900 | $9,779,100 |
| Non-Current Assets | |||||
| PPE Net | 4,599,700 | 4,146,400 | 3,763,000 | 3,482,200 | 3,221,600 |
| Investments And Advances | 8,900,100 | 5,396,500 | 6,591,800 | 6,838,000 | 3,135,600 |
| Intangibles | 1,148,600 | 1,038,600 | 915,500 | 6,700 | 0 |
| Other Non-Current Assets | 4,450,100 | 3,019,500 | 2,060,100 | 1,093,000 | 1,027,000 |
| TOTAL | $19,098,500 | $13,601,000 | $13,330,400 | $11,419,900 | $7,384,200 |
| Total Assets | $37,759,400 | $33,080,200 | $29,214,500 | $25,434,800 | $17,163,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 789,500 | 606,600 | 589,200 | 564,000 | 475,500 |
| Other current liabilities | 2,527,100 | 2,357,900 | 2,074,200 | 2,206,800 | 1,644,200 |
| TOTAL | $3,944,300 | $3,423,400 | $3,141,300 | $3,932,500 | $2,697,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,984,400 | 1,982,900 | 1,981,400 | 1,980,000 | 1,978,500 |
| Deferred Revenues | 627,700 | 458,900 | 477,900 | 442,000 | 577,700 |
| aiOther Non-Current Liabilities | 1,571,400 | 854,100 | 638,000 | 680,200 | 687,100 |
| TOTAL | $4,461,500 | $3,683,700 | $3,409,200 | $2,733,500 | $3,440,600 |
| Total Liabilities | $8,405,800 | $7,107,100 | $6,550,500 | $6,666,000 | $6,138,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 109,325 | 109,762 | 109,326 | 108,539 | 107,132 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 31,672,900 | 27,260,300 | 23,306,700 | 18,968,300 | 10,893,000 |
| Other shareholders' equity | -8,300 | -81,300 | -239,100 | -26,100 | 29,000 |
| TOTAL | $29,353,600 | $25,973,100 | $22,664,000 | $18,768,800 | $11,025,300 |
| Total Liabilities And Equity | $37,759,400 | $33,080,200 | $29,214,500 | $25,434,800 | $17,163,300 |